Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12016738 | 0.88 | FDPS (0.54) | FDPSPPARGPPARDPPARAPOLB | |
| SCHEMBL462345 | 0.86 | FDPS (0.55) | FDPSPPARGPPARDPPARAPOLB | |
| SCHEMBL10007596 | 0.84 | FDPS (0.50) | FDPSPOLBKDM4ETDP1PRSS1 | |
| SCHEMBL1546004 | 0.83 | TUBB4A (0.39) | POLBKDM4ETDP1CYP2C19KMT2A | |
| SCHEMBL7886610 | 0.82 | FDPS (0.52) | FDPSPPARGPPARDPPARAPRSS1 | |
| SCHEMBL7436823 | 0.82 | TSHR (0.58) | FDPSPPARGPPARDPPARAPOLB | |
| SCHEMBL7333971 | 0.81 | SMPD1 (0.50) | FDPSPPARGPPARDPPARASMN1; SMN2 | |
| SCHEMBL670305 | 0.81 | PPARG (0.59) | FDPSPPARGPPARDPPARACYP2C9 | |
| SCHEMBL8238025 | 0.81 | PPARG (0.59) | FDPSPPARGPPARDPPARACYP2C9 | |
| SCHEMBL16027072 | 0.81 | FDPS (0.48) | FDPSPOLBKDM4ETDP1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000221-B2 | Processes for the preparation of 4′-[3-[4-(6-Fluoro-1 ,2-benzisoxazol-3-yl)piperidino]propoxy]-3′-methoxyacetophenone and intermediates thereof | SYMED LABS LIMITED (IN) | 2015-04-07 | — | — | US | disclosed |
| US-20130261308-A1 | ONE-POT PROCESS FOR THE SYNTHESIS OF ILOPERIDONE | PROCOS. S.p.A. (IT) | 2013-10-03 | — | — | US | disclosed |
| US-20130261308-A1 | ONE-POT PROCESS FOR THE SYNTHESIS OF ILOPERIDONE | PROCOS. S.p.A. (IT) | 2013-10-03 | — | — | US | disclosed |
| US-20130190501-A1 | PROCESSES FOR THE PREPARATION OF 4'-[3-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)PIPERIDINO]PROPOXY]-3'-METHOXYACETOPHENONE AND INTERMEDIATES THEREOF | SYMED LABS LIMITED (IN) | 2013-07-25 | — | — | US | disclosed |
| WO-2011061750-A3 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | SYMED LABS LIMITED (IN) | 2012-10-04 | — | — | WO | disclosed |
| US-20120220776-A1 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | SYMED LABS LIMITED (IN) | 2012-08-30 | — | — | US | disclosed |
| US-20120220776-A1 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | SYMED LABS LIMITED (IN) | 2012-08-30 | — | — | US | disclosed |
| WO-2011061750-A2 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | SYMED LABS LIMITED (IN) | 2011-05-26 | — | — | WO | disclosed |
| WO-2011061750-A2 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | SYMED LABS LIMITED (IN) | 2011-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220776-A1 | PROCESS FOR THE PREPARATION OF ILOPERIDONE USING A NOVEL INTERMEDIATE | CYP2J2, ILF3, ILF2 | FDPS 1239/4885PPARG 360/4885PPARD 1804/4885 |
| US-20130190501-A1 | PROCESSES FOR THE PREPARATION OF 4'-[3-[4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)PIPERIDINO]PROPOXY]-3'-METHOXYACETOPHENONE AND INTERMEDIATES THEREOF | CYP4B1, CYP4X1, CYP3A4 | FDPS 168/4885PPARG 677/4885PPARD 1107/4885 |
| US-20130261308-A1 | ONE-POT PROCESS FOR THE SYNTHESIS OF ILOPERIDONE | IL2, IL1A, IL4 | FDPS 332/4885PPARG 63/4885PPARD 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.